What is Zacks Research’s Forecast for Teleflex Q1 Earnings?

Teleflex Incorporated (NYSE:TFX) – Research analysts at Zacks Research decreased their Q1 2025 earnings per share estimates for Teleflex in a research report issued on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical technology company will earn $2.77 per share for the quarter, down from their prior estimate of $3.51. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s FY2025 earnings at $14.04 EPS, Q1 2026 earnings at $3.45 EPS and FY2026 earnings at $14.97 EPS.

Several other equities research analysts also recently weighed in on the stock. Truist Financial decreased their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research note on Monday, March 3rd. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and decreased their target price for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. Finally, Piper Sandler reiterated a “neutral” rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $182.63.

Teleflex Stock Performance

NYSE TFX opened at $139.25 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex has a 1 year low of $128.55 and a 1 year high of $249.90. The company has a market capitalization of $6.46 billion, a PE ratio of 27.68, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a fifty day moving average of $169.58 and a two-hundred day moving average of $199.60.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of TFX. Apollon Wealth Management LLC raised its holdings in Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after acquiring an additional 55 shares during the last quarter. SRS Capital Advisors Inc. boosted its position in Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 60 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in Teleflex by 0.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after buying an additional 65 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its position in Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after buying an additional 66 shares during the last quarter. Finally, HighTower Advisors LLC raised its stake in shares of Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.98%. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.